Filing Details
- Accession Number:
- 0001127602-18-018931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-25 11:15:05
- Reporting Period:
- 2018-05-23
- Accepted Time:
- 2018-05-25 11:15:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-23 | 49,966 | $84.86 | 271,635 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-23 | 44,566 | $175.27 | 227,069 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-23 | 5,400 | $176.13 | 221,669 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2018-05-23 | 49,966 | $0.00 | 49,966 | $84.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-05-24 | 2022-05-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 27,811 | Indirect | By grantor retained annuity trust |
| Common Stock | 47,357 | Indirect | By grantor retained annuity trust |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $175.2738 per share represents a weighted average of sales prices ranging from $175.00 to $175.998 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $176.1281 per share represents a weighted average of sales prices ranging from $176.01 to $176.54 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable.
Billionaire Hedge Funds
